Whereas the IR-Akt transduction pathway may account for insulin resistance in the glycemic context of T2D, other disease aspects of T2D surprisingly present full response to insulin, implying “selective insulin resistance” [57]. The gene discussed is AKT1; the disease is Insulin resistance.